The Superpowers for Good Live Pitch, a quarterly televised event produced by The Super Crowd, Inc., will feature four mission-driven companies presenting their investment opportunities to a national audience on March 17. The two-hour broadcast represents a significant development in impact crowdfunding by providing direct public access to entrepreneurs in health and sustainability sectors, with viewers able to submit questions during the live show and vote for an award winner.
Impact investing encompasses a broad range of sectors, as demonstrated by the four presenting companies. My Diabetes Health focuses on insurance-covered telehealth diabetes education, reporting it has served 8,600 patients with an average 1.6-point A1C improvement. rHEALTH is developing space-validated blood diagnostics for point-of-care use, with development work connected to NASA and NIH. GigaWatt, an established distributed energy business operating for 19 years, has generated more than $54 million in revenue since 2019. BRG Therapeutics is developing novel anticancer and antiviral therapeutics with a dual-action approach across two high-need therapeutic areas.
The event's format is designed to create genuine investor engagement rather than passive viewing. Television viewers will submit questions that selected founders will answer live during the broadcast, while also voting for the SuperCrowd Award winner. A separate expert judging panel will choose a judges' selection. According to Sherwood Neiss of Crowdfund Capital Advisors, this approach creates more authentic investment evaluation. "A pitch should be persuasive—but it should also be testable," Neiss said. "When you give viewers the chance to ask questions and hear answers live, you get closer to what investing actually feels like."
Paul Lovejoy of Stakeholder Enterprise noted that audience participation changes the broadcast's dynamic, especially when questions come from people actively considering investment. "Founders can sense the difference between a passive audience and an audience that's doing diligence," Lovejoy said. "When questions come in from viewers and get asked on-air, it tends to elevate the conversation."
Industry experts emphasize different evaluation criteria for each company type. For My Diabetes Health, Léa Bouhelier-Gautreau of KingsCrowd said investors will want to understand "what drives them: patient engagement, clinician workflow, payer relationships, and retention." For rHEALTH, Neiss noted investors will want specifics about validation, regulatory plans, and first customers. Regarding GigaWatt, Bouhelier-Gautreau said investors will examine "where the defensibility sits—brand, distribution, execution capability, technology, or some combination." For BRG Therapeutics, Lovejoy emphasized that early-stage therapeutics requires a different evaluation approach focused on development milestones and validation plans.
Immediately following the broadcast, the production will host a private investor session via Zoom open to anyone interested in investing, with free registration available at https://thesupercrowd.com/26q1pitch. The Superpowers for Good Live Pitch will air live on Roku and Amazon Fire TV via the e360tv Network, with additional distribution via social channels. The event reflects the growing accessibility of impact investing opportunities to the general public, allowing viewers to participate directly in evaluating companies addressing significant health and sustainability challenges.
